U24NS107158/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2023	1
2024	2

Page 1

Time-to-event clinical trial designs: Existing evidence and remaining concerns.

Kerr WT, Auvin S, Van der Geyten S, Kenney C, Novak G, Fountain NB, Grzeskowiak C, French JA. Kerr WT, et al. Epilepsia. 2023 Jul;64(7):1699-1708. doi: 10.1111/epi.17621. Epub 2023 May 2. Epilepsia. 2023. PMID: 37073881 Free PMC article. Review.

Time to prerandomization seizure count design sufficiently assessed the safety and tolerability of perampanel for the treatment of primary generalized tonic-clonic seizures.

Kerr WT, Ngo LY, Zhu L, Patten A, Cheng JY, Reddy AS, French JA. Kerr WT, et al. Epilepsia. 2024 Aug;65(8):2412-2422. doi: 10.1111/epi.18023. Epub 2024 Jun 12. Epilepsia. 2024. PMID: 38864472 Clinical Trial.

Factors associated with placebo response rate in randomized controlled trials of antiseizure medications for focal epilepsy.

Kerr WT, Suprun M, Kok N, Reddy AS, McFarlane KN, Kwan P, Somerville E, Bagiella E, French JA. Kerr WT, et al. Epilepsia. 2024 Dec 21. doi: 10.1111/epi.18197. Online ahead of print. Epilepsia. 2024. PMID: 39707877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year